Drug Type Small molecule drug |
Synonyms Sn Mesoporphyrin, Sn-mesoporphyrin, SnMP + [6] |
Target |
Mechanism HMOX1 inhibitors(Heme oxygenase 1 inhibitors), HMOX2 inhibitors(Heme oxygenase 2 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC34H36Cl2N4O4Sn |
InChIKeyODRRBSYZKPDLOV-UHFFFAOYSA-N |
CAS Registry106344-20-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperbilirubinemia | NDA/BLA | US | - | |
Hyperbilirubinemia | NDA/BLA | - | - | |
Hyperbilirubinemia | NDA/BLA | - | - | |
Hyperbilirubinemia | NDA/BLA | - | - | |
Hyperbilirubinemia | NDA/BLA | - | - | |
Nutritional and Metabolic Diseases | Phase 3 | US | 01 May 2002 | |
Jaundice | Phase 2 | US | 16 Oct 2013 | |
Jaundice, Neonatal | Phase 2 | US | 16 Oct 2013 | |
Hyperbilirubinemia, Neonatal | Phase 2 | PL | 01 Aug 2008 | |
Hyperbilirubinemia, Neonatal | Phase 2 | ES | 01 Aug 2008 |
Phase 2 | 91 | Phototherapy | gdtdswhziu(hbzikjzotv) = sdozzgzunf vqxczgoumu (fnpbnwnhzr, tvfmsugoks - qhnwzazput) View more | - | 13 Nov 2019 |